Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly longer » significantly lower (Expand Search), significantly larger (Expand Search), significantly shorter (Expand Search)
longer decrease » larger decrease (Expand Search), linear decrease (Expand Search), largest decrease (Expand Search)
decrease cgas » increased cgas (Expand Search), increases cgas (Expand Search)
Showing 141 - 160 results of 1,791 for search '(( significant decrease cgas ) OR ( significantly longer decrease ))', query time: 0.30s Refine Results
  1. 141
    Development of hamstring strength throughout the LIST.

    Development of hamstring strength throughout the LIST. by Dominic Michael Rasp (19959412)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 142
    Summary of HSS and LSI during the LIST.

    Summary of HSS and LSI during the LIST. by Dominic Michael Rasp (19959412)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 143
    S2 Raw data -

    S2 Raw data - by Dominic Michael Rasp (19959412)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 144
    Set-up of the optimized 90:20 Isometric Posterior Chain Test.

    Set-up of the optimized 90:20 Isometric Posterior Chain Test. by Dominic Michael Rasp (19959412)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 145
    Characterization of the controlled cortical impact model and selection of sub-convulsive dose of PTZ.

    Characterization of the controlled cortical impact model and selection of sub-convulsive dose of PTZ. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 146
    Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus.

    Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 147
    S1 Data -

    S1 Data - by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 148
    Modified Racine score for PTZ-induced seizures. From [28].

    Modified Racine score for PTZ-induced seizures. From [28]. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 149
    Time-dependent effects of CCI on glutamate transporter mRNA.

    Time-dependent effects of CCI on glutamate transporter mRNA. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 150
    Chronic, but not acute, CCI mice have increased susceptibility to 30mg/kg PTZ.

    Chronic, but not acute, CCI mice have increased susceptibility to 30mg/kg PTZ. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 151
    Delayed treatment with ceftriaxone reduced seizure susceptibility in CCI mice.

    Delayed treatment with ceftriaxone reduced seizure susceptibility in CCI mice. by Simone A. A. Romariz (16541996)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 152
    Time-varying effect of anti-coagulation regime on sub-distribution hazards for all-cause mortality.

    Time-varying effect of anti-coagulation regime on sub-distribution hazards for all-cause mortality. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 153
    Baseline characteristics of study cohort (n, %) showing the probability of any differences between event free, stroke and all-cause mortality groups between those exposed to Warfarin or DOACs.

    Baseline characteristics of study cohort (n, %) showing the probability of any differences between event free, stroke and all-cause mortality groups between those exposed to Warfar... by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 154
    Unadjusted cumulative incidence of stroke and all-cause mortality by type of anti-coagulant.

    Unadjusted cumulative incidence of stroke and all-cause mortality by type of anti-coagulant. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 155
    Summary of multivariate adjusted cause-specific hazards and the subdistribution hazards for comparison.

    Summary of multivariate adjusted cause-specific hazards and the subdistribution hazards for comparison. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 156
    Crude incidence rates of stroke and all-cause mortality.

    Crude incidence rates of stroke and all-cause mortality. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 157
    Time-Varying effect of anti-coagulation regimen on sub-distribution hazards for stroke.

    Time-Varying effect of anti-coagulation regimen on sub-distribution hazards for stroke. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 158
    Unadjusted cumulative incidence of stroke and all-cause mortality.

    Unadjusted cumulative incidence of stroke and all-cause mortality. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 159
    Multivariate analysis of the cause-specific hazard ratio (CSHR) for all-cause mortality, interpreted as time-averaged effects.

    Multivariate analysis of the cause-specific hazard ratio (CSHR) for all-cause mortality, interpreted as time-averaged effects. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 160
    Multivariate analysis of the cause-specific hazard ratio (CSHR) for stroke.

    Multivariate analysis of the cause-specific hazard ratio (CSHR) for stroke. by Simon de Lusignan (2416)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: